Prolastin-C Liquid
NDC 13533-705, Alpha1-Proteinase Inhibitor (Human), injection, solution, from GRIFOLS USA, LLC.
- Product NDC
- 13533-705
- Status
- Listed
- Labeler
- GRIFOLS USA, LLC
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Product type
- PLASMA DERIVATIVE
- Marketing category
- BLA
- Application
- BLA103174
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/13533-705 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- .ALPHA.1-PROTEINASE INHIBITOR HUMAN1000 mg/20mL
Pharmacologic classes
Human alpha-1 Proteinase Inhibitor [EPC]; Trypsin Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 13533-705-01 | 13533070501 | 1 VIAL in 1 CARTON (13533-705-01) / 20 mL in 1 VIAL (13533-705-11) |
| 13533-705-31 | 13533070531 | 1 VIAL in 1 CARTON (13533-705-31) / 10 mL in 1 VIAL (13533-705-32) |
| 13533-705-51 | 13533070551 | 1 VIAL in 1 CARTON (13533-705-51) / 80 mL in 1 VIAL (13533-705-52) |
Linked data
RxNorm, label and prices
Related lookups
Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=13533-705
Use it
Look up 13533-705 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/13533-705 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 13533-705. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.